Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis: a cohort study in the TARGET-DERM AD Registry

Name: Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis: a cohort study in the TARGET-DERM AD Registry
Creator: Michael Haft
Published: 2023-11-14T06:22:33.667Z
Keywords: Dermatology, Therapeutics, Biologic Therapy, Atopic Dermatitis, Drug Utilization

Haft, Michael; Knapp, Keith; Claxton, Ami; Munoz, Breda; Crawford, Julie; Balu, Sanjeev; Schneider, Shannon; Eichenfield, Dawn; Silverberg, Jonathan; Thaci, Diamant; Bagel, Jerry; Rhoads, Jamie; Paller, Amy; Eichenfield, Lawrence

doi:10.17632/72ypdspmfm.1

Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis: a cohort study in the TARGET-DERM AD Registry

Published: 14 November 2023| Version 1 | DOI: 10.17632/72ypdspmfm.1

Contributors:

Michael Haft, Keith Knapp, Ami Claxton, Breda Munoz, Julie Crawford, Sanjeev Balu, Shannon Schneider, Dawn Eichenfield, Jonathan Silverberg, Diamant Thaci, Jerry Bagel, Jamie Rhoads, Amy Paller, Lawrence Eichenfield

Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis: a cohort study in the TARGET-DERM AD Registry

Description

Files

Categories

Funding

Licence